Overview
- Akums Drugs and Pharmaceuticals told the NSE and BSE that President–Finance Rajkumar Bafna’s resignation takes effect on December 31 under SEBI Regulation 30.
- Bafna’s December 3 email to management said he was resigning "due [to] Delhi pollution level" and asked to be "relieve[d] asap," offering help during the transition.
- Chief financial officer Sumeet Sood acknowledged the exit and, citing Bafna’s health issues, confirmed the formal relieving on December 31.
- Co-founder Sanjeev Jain said Bafna had a persistent cough aggravated by the capital’s air, reinforcing that pollution was the reason for his decision.
- Delhi’s air quality hovered in the very poor to severe range around AQI 390–403 with GRAP Stage-4 curbs in place, and coverage cast the exit as a rare public instance of a senior listed-company executive citing pollution.